Document Page: First | Prev | Next | All | Image | This Release | Search
File: 121096_sep96_decls16_0003.txt
Subject: DOD IMMUNIZATION PROGRAM FOR BIOLOGICAL WARFARE
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: DOD IMMUNIZATION PROGRAM FOR BIOLOGICAL WARFARE
Document Number: 1
Folder Seq #: 80
Nov 26, 93
6205. 3
3. The try of Qefense for He-Alth Affairs shall:
a. Serve as the advisor to the Secretary of Defense as in DoD Directive 5136.1
(reference (d)) on the DoO Immunization Program for Biological Warfare Defense.
b. In consultation with the DoD Executive Agent, the Secretaries of the Military
Departments, and the Chair of the Armed Forces Epidemiological Board, idervtify vac-
cines available to protect against biological threat agents designated by the Chairman
of the Joint Chiefs of Staff and recommend appropriate Immunization protocols.
c. Issue instructions to the Military Departments and the other appropriate DoD
Components on the immunization of DoD personnel, under the guidelines of this Direc-
tive, and monitor and evaluate the Implementation of #me instructions.
4. The krmy, as the DoD Executive Agent for the Immunization
PrQgram for Blobgieal Warfare Defense, shall:
a. Besides those responsibilities in the Deputy @stary of Defense Memoran-
dum and the Joint Service Agreement (references (a) and (@), do the following to en-
hance the DoD Immunization Program for Biological Warfare Defense, and report an-
nually through the Assistant Secretary of Defense for Heafth Affairs (ASD(HA)) to the
Secretary of Defense the capability to carryout time policies:
(1) Vaceine Research and Develol2ment
Priorities developed in coordination with the ASD(HA). Me Chairman of
shall Include
the development of vaccines against validated biological warlare threat agents for
which none exist, improvement of vaccines that are unacceptable in the time they take
to produce immunity or in the level of immunity they produce or are inadequate be-
cause of the num@r of doses required to achieve Immunity, assessment of the effec-
tiveness of vaccines against biological warfare threat agents in their likely modes of use
(e.g., aerosols), and development of muftivalent vaccines that will produce protective
immunity after a single vaccination. Vaccines must be either licensed by the Food and
Drug Administration (FDA) or have been designated, under FDA requirements, *for use
as investigational now drugs (INDs)," as in 21 CFR 50 (reference (g)).
(2) Vaccine Accuosition and Stockpiling
b. Develop and maintain a DoD capability to acquire and stoc@ile adequate
quantities of vaccines to protect the programed force against all validated biological
warfare threat agents for which suitable vaccines exist.
c. On an annual basis, provide information and recommendations, in coordina-
tion with the Secretaries of the Military Departments and the Chair of the Armed Forces
3
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 8 f:/Week-36/BX003203/DOD IMMUNIZATION PROGRAM FOR BIOLOGICAL WARFARE/dod immunization program for biological warfare:12069615355317
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DOD IMMUNIZATION PROGRAM FOR BIOLOGICAL WARFARE
Folder Seq # = 80
Subject = DOD IMMUNIZATION PROGRAM FOR BIOLOGICAL WARFARE
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 06-DEC-1996